- Home
- CPT vs ELAN Comparison
CPT vs ELAN Comparison
Compare CPT & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPT | ELAN |
|---|---|---|
| Founded | 1993 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 11.8B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CPT | ELAN |
|---|---|---|
| Price | $112.97 | $24.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $115.28 | $27.89 |
| AVG Volume (30 Days) | 976.7K | ★ 3.9M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 136.00 | N/A |
| EPS | ★ 0.40 | 0.11 |
| Revenue | $12,967,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | N/A | $8.21 |
| Revenue Next Year | $2.60 | $5.31 |
| P/E Ratio | $283.25 | ★ $223.82 |
| Revenue Growth | ★ 81.69 | 6.22 |
| 52 Week Low | $96.53 | $13.39 |
| 52 Week High | $119.81 | $27.72 |
Technical Indicators
Market Signals| Indicator | CPT | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 55.34 |
| Support Level | $105.41 | $22.33 |
| Resistance Level | $116.59 | $25.58 |
| Average True Range (ATR) | 1.95 | 0.86 |
| MACD | -0.36 | -0.01 |
| Stochastic Oscillator | 41.99 | 73.51 |
Price Performance
Historical ComparisonAbout CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.